Health Section: Cell and Gene Therapies: Cost Approaches and Actuaries’ Key Role

<p>Listen to Jackie Lee and Ned Pojskic discuss how insurers and PBMs have a unique and creative challenge to collaborate with the pharmaceutical industry to innovate new mechanisms for single-use, high-cost therapies. Actuaries need to consider how cell and gene therapies are becoming more a platform for the development of new drugs and its impact on their analyses.</p>